AKT1 and colorectal carcinoma: In support of unchanged AKT, Penna et al. demonstrated no alteration in AKT phosphorylation despite seeing reductions in skeletal muscle IGF1 in the C26 model of CRC cachexia (Penna et al., 2010a).